At the beginning of this year, Pharmaceutical Commerce called 2017 “Year Zero” in the march toward end-to-end pharma traceability. The ostensible reason was that November 2017 was to be the date when effectively all new pharmaceutical packages entering US commercial […]
Read MoreAccenture has been offering a variety of software solutions, mostly for healthcare providers but with some overlap with meeting pharma industry needs, for several years; now it has targeted the patient support (hub) programs run specifically by pharma with the […]
Read More
QPharma (Morristown, NJ) has been active in the pharma sales-operations support field for over two decades and has a client base of over 100 firms for such services as sample accountability, KOL management and master-data management of physicians. Last year, […]
Read More
One of the great imponderables of the coming era of traceability of pharmaceutical shipments throughout the supply chain—the goal of the Drug Supply Chain Security Act (DSCSA)—is: who owns the data? Pharma manufacturers generate the serial numbers and other identifiers […]
Read MoreA key part of delivering pharmaceutical samples to physicians (whether through online systems or by a face-to-face interaction with a sales rep) is gathering the required physician’s signature—the “dreaded ‘acknowledgement of content’ record,” as James Stepkoski, national sales manager at […]
Read MoreLash Group, the AmerisourceBergen business unit that is one of the leaders in providing outsourced hub services for patients, has announced a new IT platform, to be used internally by its patient-services teams, but also to collaborate with and provide […]
Read More
Pharma traceability technology appears to be taking a small step backward, in order to make a big leap forward in the future as end-to-end traceability of pharma packages becomes a nearer-term regulatory goal. The backward step (a characterization which advocates […]
Read MoreZephyr Health (San Francisco) is one of a handful of IT companies, focused on life sciences, employing cloud-based “Big Data” techniques to ferret out relationships among key opinion leaders (KOLs) and their affiliations with health systems, professional organizations and related […]
Read MoreAccording to Veeva OpenData, the life sciences industry has expanded its capacity to treat patients addicted to pain killers by 91%. However, treatment center coverage remains uneven in the hardest-hit rural communities where emergency services may be limited, treatment options […]
Read MoreAny business doing practically anything has a customer list. It remains a very basic, yet very challenging, part of how the pharma industry interacts with its primary customers, the healthcare providers: reliably identifying their location, credentials and affiliations (Fig. 1). […]
Read More